#Peptides

All articles tagged with "Peptides"

Biopharma’s Week in Focus: Peptide Policy, Pipeline Momentum, and the Start of Earnings Scrutiny

A sparse but telling weekly roundup from Endpoints News points to three pressures shaping biotech right now: regulation, clinical momentum, and investor scrutiny.

Key Takeaways

Endpoints News highlighted RevMed’s success, FDA peptide reclassification, and the start of Q1 earnings season.
The supplied text also mentions Johnson & Johnson’s confidence in navigating biosimilar competition.

DT Editorial Team·Apr 18, 2026·via endpoints.news

FDA Plans Outside Review of Broader Access to Certain Peptides

The FDA plans to convene outside advisers to discuss whether compounding pharmacies should be allowed broader manufacturing access for certain peptides, opening a consequential regulatory debate around supply, oversight,

Key Takeaways

The FDA plans an outside advisory discussion on broader access to certain peptides.
The question centers on whether compounding pharmacies should be allowed wider manufacturing room.

DT Editorial Team·Apr 15, 2026·via statnews.com